Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(33), p. 9007-9007, 2015
DOI: 10.1200/jco.2015.33.15_suppl.9007
Links
Tools
A phase Ib/II study of BRAF inhibitor (BRAFi) encorafenib (ENCO) plus MEK inhibitor (MEKi) binimetinib (BINI) in cutaneous melanoma patients naive to BRAFi treatment.
Journal article published in 2015 by
Ryan J. Sullivan,
Elena Élez,
Jeffrey S. Weber,
Sapna Pradyuman Patel,
Reinhard Dummer,
Wilson H. Miller,
David Cosgrove,
Matteo S. Carlino 
,
Daniel Shao-Weng Tan,
Celeste Lebbe,
Heiko Maacke,
Tiziana Cipani,
Panagiotis Nikolopoulos,
Mounir Aout,
Laure A. De Parseval
and other authors.
,
Daniel Shao-Weng Tan,
Celeste Lebbe,
Heiko Maacke,
Tiziana Cipani,
Panagiotis Nikolopoulos,
Mounir Aout,
Laure A. De Parseval
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 